Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amag Pharmaceuticals (AMAG)

Amag Pharmaceuticals (AMAG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 477,469
  • Shares Outstanding, K 34,725
  • Annual Sales, $ 327,750 K
  • Annual Income, $ -466,460 K
  • 60-Month Beta 0.89
  • Price/Sales 1.45
  • Price/Cash Flow N/A
  • Price/Book 1.85
Trade AMAG with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.30
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.01
  • Number of Estimates 4
  • High Estimate 0.11
  • Low Estimate -0.13
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +102.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.35 +3.00%
on 10/14/20
13.76 -0.07%
on 11/13/20
+0.38 (+2.84%)
since 10/13/20
3-Month
8.62 +59.51%
on 09/24/20
13.80 -0.36%
on 10/01/20
+3.18 (+30.09%)
since 08/13/20
52-Week
4.41 +211.79%
on 03/18/20
13.80 -0.36%
on 10/01/20
+4.06 (+41.90%)
since 11/13/19

Most Recent Stories

More News
Third Pole Therapeutics Expands Board of Directors

, /PRNewswire/ -- , a privately held company developing and delivering critical life-sustaining cardio-pulmonary therapies, announced today that it has added two seasoned pharmaceutical executives to...

AMAG : 13.75 (+0.15%)
SELB : 4.22 (-1.40%)
Global IV and Oral Iron Drugs Market (2021 to 2026) - Featuring Vifor Pharma, Daiichi Sankyo & AMAG Pharmaceuticals Among Others - ResearchAndMarkets.com

The "IV and Oral Iron Drugs Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

AMAG : 13.75 (+0.15%)
GNHAF : 130.0000 (-1.62%)
Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients' unmet needs and solve therapeutic problems,...

AQST : 4.58 (-9.13%)
FRLN : 14.91 (-1.45%)
AMAG : 13.75 (+0.15%)
VRTX : 212.55 (-0.20%)
SYK : 242.69 (-1.26%)
SCYX : 7.78 (-1.27%)
ABBV : 107.74 (+0.38%)
DCTH : 18.01 (-1.58%)
NRX : 0.14 (+7.69%)
Palatin (PTN) to Report Q2 Earnings: What's in the Cards?

Vyleesi sales are likely to be in focus when Palatin (PTN) releases results for the second quarter of fiscal 2021.

ALXN : 152.75 (-0.59%)
AMAG : 13.75 (+0.15%)
PTN : 0.7820 (-4.63%)
CARA : 18.35 (-4.72%)
Exicure Announces Appointment of James Sulat to Board of Directors

Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA(TM)) technology, today announced the appointment of James Sulat to its Board...

AMAG : 13.75 (+0.15%)
MNTA : 52.48 (-0.02%)
INRLF : 13.3600 (-3.68%)
XCUR : 2.17 (-3.56%)
Covis Group Completes Acquisition of AMAG Pharmaceuticals

and ZUG, , /PRNewswire/ -- Covis Group S.à r.l. ("Covis") today announced the completion of its acquisition of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) through the successful tender offer for all of...

AMAG : 13.75 (+0.15%)
Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc., Contango Oil & Gas Company, Eaton Vance Corp., and MobileIron, Inc.

NEW YORK, NY / ACCESSWIRE / November 13, 2020 /

AMAG : 13.75 (+0.15%)
MCF : 4.87 (-1.81%)
EV : 73.07 (-0.98%)
MOBL : 7.04 (+0.07%)
Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc., Contango Oil & Gas Company, Eaton Vance Corp., MobileIron, Inc., Seacoast Commerce Banc Holdings, Perceptron, Inc., Standard AVB Financial Corp., Virginia National Bankshares Corporation and Virtusa Corporation

, /PRNewswire/ --

NKSH : 33.16 (-1.25%)
PRCP : 6.97 (+0.07%)
SCBH : 17.2500 (+1.47%)
AMAG : 13.75 (+0.15%)
MCF : 4.87 (-1.81%)
EV : 73.07 (-0.98%)
MS : 76.87 (-1.99%)
VABK : 31.9900 (+7.64%)
VRTU : 51.33 (+0.04%)
ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - VRTU, AMAG, EV, CBMG

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

VRTU : 51.33 (+0.04%)
AMAG : 13.75 (+0.15%)
EV : 73.07 (-0.98%)
CBMG : 19.75 (unch)
Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc., Eaton Vance Corp., MobileIron, Inc., and Seacoast Commerce Banc Holdings

EQNX::TICKER_START (NASDAQ:AMAG),(NYSE:EV),(NASDAQ:MOBL),(Other OTC:SCBH), EQNX::TICKER_END

MOBL : 7.04 (+0.07%)
AMAG : 13.75 (+0.15%)
EV : 73.07 (-0.98%)
SCBH : 17.2500 (+1.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Ferumoxytol, the...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 13.76
1st Resistance Point 13.76
Last Price 13.75
1st Support Level 13.75
2nd Support Level 13.74
3rd Support Level N/A

See More

52-Week High 13.80
Last Price 13.75
Fibonacci 61.8% 10.21
Fibonacci 50% 9.10
Fibonacci 38.2% 8.00
52-Week Low 4.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar